H35.30
Unspecified macular degeneration
Clinical Classification Guidelines
Inclusion Terms
- Age-related macular degeneration
Medical Intelligence & Overview
Unspecified macular degeneration is a general term used when a doctor identifies damage or deterioration in the macula, the central part of the retina responsible for sharp, detailed vision. Although often linked to age-related changes, this condition can impair vision significantly if left unmanaged. The specific diagnosis 'unspecified' indicates that the exact form or stage of macular degeneration has not been specified, but it still warrants attention due to its potential impact on eyesight.
Causes & Symptoms
Clinical Causes: Aging process naturally leading to changes in the retina Genetic factors influencing susceptibility Lifestyle choices such as smoking or poor nutrition Environmental influences, including prolonged exposure to sunlight Other underlying eye conditions that may contribute
Key Symptoms: Gradual loss of central vision, making daily activities like reading or recognizing faces difficult Straight lines appearing crooked or distorted (visual distortion) Decreased contrast sensitivity, making objects appear less distinct Difficulty adapting to low light conditions Appearance of blurry or dark areas in the central visual field
Diagnostic & Treatment
Diagnosis Path: Diagnosis of macular degeneration involves comprehensive eye examinations including dilated retinal exams and specialized imaging tests. Common methods include optical coherence tomography (OCT) to view retinal layers, and fluorescein angiography to assess blood flow and detect abnormal blood vessels. Regular eye screenings are essential for early detection, especially for those at increased risk, such as older adults.
Treatment Protocols: While there is no cure for age-related macular degeneration, several options can help manage the condition and slow its progression. These include: - Nutritional supplements rich in vitamins C and E, zinc, lutein, and zeaxanthin - Anti-VEGF (vascular endothelial growth factor) injections to inhibit abnormal blood vessel growth in wet AMD - Laser therapy to target abnormal blood vessels - Low vision aids and adaptive devices to enhance remaining vision - Regular monitoring and follow-up with eye care professionals to track disease progression Engaging in healthy lifestyle choices, such as quitting smoking and maintaining a balanced diet, can also contribute to better eye health.
Clinical Advice & FAQs
Billing Guidance
Is H35.30 a billable ICD-10 code?
Yes, H35.30 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.30?
Clinical documentation must specify the nature of Unspecified macular degeneration and any associated comorbidities for accurate reporting.
Cite this Clinical Reference